期刊文献+

肝脏储备功能相关系统对肝硬化失代偿期预后的评估与分析 被引量:3

Liver reserve function for assessing and analyzing prognosis of decompensated hepatocirrhosis
下载PDF
导出
摘要 目的运用终末期肝病模型(MELD)评分与CTP分级等对失代偿期肝硬化患者短期生存状况进行相关性回顾性分析,预测失代偿期肝硬化患者3个月、1年的病死率。方法应用MELD、MELD—Na计算公式及CTP分级分别对119例肝硬化失代偿期患者进行评分及分级,比较不同MELD评分(≤9、10~19、20~29、≥30分)组及CTP不同分级患者(A、B、C级)3月和1年的病死率,并分析肝硬化失代偿期患者随访3月、1年预后的临床特征。结果MELD评分≤9、10~19、20.29、≥30分者,3个月内死亡率分别为:2.17%,10.71%、64.29%和100%;1年病死率分别为:26.09%、32.14%、57.14%和100%,各组间差异有显著性(3月组P〈0.05,1年组P〈0.01)。表明肝硬化失代偿期患者短期(3月与1年)病死率与MELD分值有关。以R〉18分为界分组比较3月、1年的病死率,结果显示〉18分的3月、1年病死率明显高于≤18分组,差异有极显著性(两组P〈0.01)。CTP分级显示:A、B、C级3个月内各组死亡率分别为6.78%、15.38%、42.86%,各组差异有极显著性(P〈0.01)。 Objective To retrospectively analyze the short-term survival status of decompensated hepatocirrhosis by the Model for End-Stage Liver Disease ( MELD ) and Child-Turcotte-Pugh ( CTP ) score and to predict 3-month and one-year mortality rates in decompensated hepatocirrhosis. Methods MELD, MELD-Na, and CTP score decompensated hepatocirrhosis were used to classify and graded decompensated hepatocirrhosis in 119 patients.The 3-month and one-year morality rates were compared among patients with different MELD scores ( ≤9, 10-19, 20-29, and ≥30 ) or different CTP classification ( A, B, and C ). The clinical features were analyzed in the patienes during a 3- month and a one-year follow-up. Results The 3-month mortality rate was 2.17 % for MELD ≤ 9, 10.71% for 10-19, 64.29 % for 20-29, and 100 % for I〉30; and the one-year mortality was 26.09%, 32.14%, 57.14 %, and 100 %, respectively. The short-term mortality was associated with MELD scores. If R 〉 18 was used as a standard, the 3-month and one-year mortality rates were significantly higher in the group with R 〉 18 than in the group with R= 18 ( P〈 0.01 for both comparisons ). The 3-month mortality rate was 6.78 % for CTP A, 15.38 % for B, and 42.86 % for C ( P〈 0.01 and the one-year mortality was 11.86 %, 38.46 %, and 90.48 %, respectively ( P〈 0.05 ). MELD-Na was related to the short-term mortality ( 3 months and 1 year ) in decompenated hepatocirrosis ( P 〈 0.01 ). Conclusions Both MELD and CTP scores can accurately predict the short-term prognosis in patients with decompensated hepatocirrhosis.
出处 《国际医药卫生导报》 2012年第3期333-337,共5页 International Medicine and Health Guidance News
关键词 肝硬化失代偿期患者 肝脏储备功能 预后 MELD评分 肝硬化患者 年病死率 终末期肝病模型 评估 Hepatocirrhosis Model for End-Stage Liver Diseas Child-Turcotte-Pugh score
  • 相关文献

参考文献13

  • 1Kamath PS, Wiesner RH, Malinchoc M, et al.A model to predict survival in patients with endstage liver disease [J]. Hepatology, 2001, 33 ( 2): 464-470.
  • 2FREEMANRB JR, WIESNER RH, HARPER A, et al.The new liver allocation system: moving toward evidence-based transplantation policy[J]. Liver Transplant, 2002, 8 (9): 851-858.
  • 3RUF AE, KREMERS WK, CHAVEZ LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone [J].Liver Transplant, 2005, 11 (3): 336-343.
  • 4HEUMAN DM, ABOUASSI SG, HABIB A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are high risk for early death[J]. Hepatology, 2004, 40 ( 10 ): 802-810.
  • 5中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14006
  • 6梁扩寰,李绍白.肝脏病学[M].2版.北京:人民卫生出版社,2004:849-951.
  • 7Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence based transplantation policy[J]. Liver Transpl, 2002, 8: 851-858.
  • 8Malinchoc M, Kamath PS, Gordon FD, et al. A model to pedict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31 (4): 864-871.
  • 9RUF AE, KREMERS WK, CHAVEZ LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone [J]. Liver Transplant, 2005, 11 (3): 336-343.
  • 10HEUMAN DM, ABOUASSI SG, HABIB A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are high risk for early death[J]. Hepatology, 2004, 40( 10 ): 802-810.

共引文献14005

同被引文献25

  • 1Kenneth SH Chok,See Ching Chan,James YY Fung,Tan To Cheung,Albert CY Chan,Sheung Tat Fan,Chung Mau Lo.Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores[J].Hepatobiliary & Pancreatic Diseases International,2013,12(3):256-262. 被引量:6
  • 2吴杭源,朱银芳,华忠,徐淑凡,过小叶,姚上志.苦参素联合胸腺肽α1治疗失代偿期肝硬化的抗病毒疗效观察[J].中国生化药物杂志,2014,34(5):143-145. 被引量:15
  • 3Malinchoc M,Kamath PS,Gordon FD. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J].{H}HEPATOLOGY,2000,(04):864-871.
  • 4Wiesner R,Edwards E,Freeman R. Model for end-stage liver disease(MELD)and allocation of donor livers[J].{H}GASTROENTEROLOGY,2003,(01):91-96.
  • 5Jeong EM,Hwang SG,Park HH. The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis[J].Taehan Kan Hakhoe Chi,2003,(02):98-106.
  • 6Arroyo V,Gines P,Gerbes AL. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club[J].{H}HEPATOLOGY,1996,(01):164-176.
  • 7Kappa SF,Gorden DL,Davidson MA. Intraoperative blood loss predicts hemorrhage-related reoperation after orthotopic liver transplantation[J].{H}American Surgeon,2010,(09):969-973.
  • 8Sezer S,Karakan S,Erismis B. Risk factors for kidney impairment and differential impact of liver transplantation on renal function[J].{H}TRANSPLANTATION PROCEEDINGS,2011,(02):609-611.
  • 9Fabrizi F,Dixit V,Martin P. Pre-transplant kidney function predicts chronic kidney disease after liver transplant:meta-analysis of observational studies[J].{H}Digestive Diseases and Sciences,2011,(05):1282-1289.
  • 10Audet M,Piard T,Panaro F. Incidence and clinical significance of bacterial and fungal contamination of the Preservation solution in liver transplantation[J].{H}Transplant Infectious Disease,2011,(01):84-88.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部